Current Perspectives on Human Papillomavirus (HPV)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 1186
Special Issue Editors
2. University Department of Health Studies, University of Split, 21000 Split, Croatia
Interests: Human Papillomavirus (HPV)
Interests: microbiome; microbiota; gut microbiome; vaginal microbiome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
A highly prevalent human papillomavirus (HPV) infection can be responsible for a myriad of health issues, thus unveiling the need for a comprehensive overview of the latest research developments and insights into various aspects of this viral agent. This Special Issue aims to cover the most important aspects of human papillomavirus (HPV) infections, including fundamental research, diagnostics, treatment and prevention strategies. The scope of this Special Issue includes research on the biology and molecular mechanisms of HPV, as well as studies on the clinical aspects of HPV-related diseases.
In terms of diagnostics and treatment, the Special Issue will focus on the latest advancements in diagnostic methods, particularly concerning molecular tests and their use in disease screening strategies, but also novel treatment approaches such as immunotherapy and targeted treatments. Additionally, the Special Issue will provide insights into HPV-related diseases, including the associated complications and malignancies. Likewise, prevention strategies represent an important focus of this Special Issue, including vaccination and screening as two crucial strategies for prevention and early detection, respectively.
We invite experts from the scientific fields of microbiology, virology, pathology, infectious diseases, dermatology, oncology, gynecology and urology to share their latest research results, experiences and innovations in the field of HPV research and prevention.
Dr. Vanja Kaliterna
Dr. Tomislav Meštrović
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Human Papillomavirus (HPV)
- molecular mechanisms
- diagnosis
- treatment
- prevention
- vaccination
- screening
- immunotherapy
- cancer
